- Home
- TRMK vs VCYT Comparison
TRMK vs VCYT Comparison
Compare TRMK & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRMK
- VCYT
- Stock Information
- Founded
- TRMK 1889
- VCYT 2006
- Country
- TRMK United States
- VCYT United States
- Employees
- TRMK N/A
- VCYT N/A
- Industry
- TRMK Major Banks
- VCYT Medical Specialities
- Sector
- TRMK Finance
- VCYT Health Care
- Exchange
- TRMK Nasdaq
- VCYT Nasdaq
- Market Cap
- TRMK 2.4B
- VCYT 2.4B
- IPO Year
- TRMK 1987
- VCYT 2013
- Fundamental
- Price
- TRMK $40.23
- VCYT $32.52
- Analyst Decision
- TRMK Buy
- VCYT Buy
- Analyst Count
- TRMK 4
- VCYT 9
- Target Price
- TRMK $41.00
- VCYT $39.89
- AVG Volume (30 Days)
- TRMK 244.6K
- VCYT 1.2M
- Earning Date
- TRMK 10-21-2025
- VCYT 08-06-2025
- Dividend Yield
- TRMK 2.38%
- VCYT N/A
- EPS Growth
- TRMK 17.82
- VCYT N/A
- EPS
- TRMK 3.56
- VCYT 0.34
- Revenue
- TRMK $758,379,000.00
- VCYT $479,129,000.00
- Revenue This Year
- TRMK $58.78
- VCYT $14.19
- Revenue Next Year
- TRMK $4.52
- VCYT $9.68
- P/E Ratio
- TRMK $11.33
- VCYT $93.90
- Revenue Growth
- TRMK 58.50
- VCYT 19.91
- 52 Week Low
- TRMK $29.77
- VCYT $22.61
- 52 Week High
- TRMK $40.81
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- TRMK 60.62
- VCYT 68.54
- Support Level
- TRMK $39.56
- VCYT $29.38
- Resistance Level
- TRMK $40.81
- VCYT $30.69
- Average True Range (ATR)
- TRMK 0.70
- VCYT 1.11
- MACD
- TRMK 0.05
- VCYT 0.16
- Stochastic Oscillator
- TRMK 66.46
- VCYT 95.74
About TRMK Trustmark Corporation
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.